Perspective Therapeutics, Inc.

CATXReported to SECin USCIK 0000728387Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 7. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 7
Form 4 lines at Perspective Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Lantheus Alpha Therapy, LLC—Open-market sell$526,051167,149 sharesSep 8, 2026Lantheus Alpha Therapy, LLC$526,051Sell · Sep 8Open-market sell167,149Sep 8, 2026
Lantheus Alpha Therapy, LLC—Open-market sell$250,89680,783 sharesSep 8, 2026Lantheus Alpha Therapy, LLC$250,896Sell · Sep 8Open-market sell80,783Sep 8, 2026
Lantheus Alpha Therapy, LLC—Open-market sell$131,21942,129 sharesSep 4, 2026Lantheus Alpha Therapy, LLC$131,219Sell · Sep 4Open-market sell42,129Sep 4, 2026
Lantheus Alpha Therapy, LLC—Open-market sell$111,57435,769 sharesSep 4, 2026Lantheus Alpha Therapy, LLC$111,574Sell · Sep 4Open-market sell35,769Sep 4, 2026
Lantheus Alpha Therapy, LLC—Open-market sell$245,61078,145 sharesSep 4, 2026Lantheus Alpha Therapy, LLC$245,610Sell · Sep 4Open-market sell78,145Sep 4, 2026